Use and misuse of thyroid hormone.

Area of Science:

• Endocrinology
• Pharmacology

Background:

• Synthetic thyroxine (T4) is now the preferred treatment for chronic thyroid hormone replacement.
• It is used for hypothyroidism and thyroid cancer management.
• Liothyronine (T3) is generally for short-term use, with limited chronic applications.

Purpose of the Study:

• To review the current applications of synthetic thyroxine and liothyronine in thyroid hormone therapy.
• To discuss controversies and limitations in thyroid hormone treatment regimens.
• To evaluate the evidence for off-label uses of thyroid hormone.

Main Methods:

• Literature review of established and emerging thyroid hormone therapies.
• Analysis of clinical guidelines and research on hypothyroidism and thyroid cancer treatment.
• Assessment of evidence for non-standard thyroid hormone applications.

Main Results:

• Synthetic thyroxine monotherapy is standard for hypothyroidism and thyroid cancer.
• Liothyronine is primarily for short-term use, including specific cancer treatments and myxedema coma.
• Chronic liothyronine use is rare, reserved for thyroxine intolerance.
• Controversies exist regarding combination therapy and thyroid extracts.
• Misuse for weight loss and in euthyroid patients is noted.
• Insufficient evidence supports use in depression or non-thyroidal illnesses.

Conclusions:

• Synthetic thyroxine is the cornerstone of chronic thyroid hormone therapy.
• Liothyronine has specific, predominantly short-term, indications.
• Evidence does not support widespread use of alternative regimens or off-label applications.
• Further research is needed for specific patient populations and novel treatment strategies.